Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
293,061,432
-
Total 13F shares
-
104,032,627
-
Share change
-
-3,738,353
-
Total reported value
-
$524,646,193
-
Put/Call ratio
-
68%
-
Price per share
-
$5.03
-
Number of holders
-
140
-
Value change
-
+$3,617,961
-
Number of buys
-
76
-
Number of sells
-
57
Institutional Holders of AbCellera Biologics Inc. - Ordinary Shares (ABCL) as of Q3 2025
As of 30 Sep 2025,
AbCellera Biologics Inc. - Ordinary Shares (ABCL) was held by
140 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
104,032,627 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Capital World Investors, BAILLIE GIFFORD & CO, TWO SIGMA INVESTMENTS, LP, TWO SIGMA ADVISERS, LP, ArrowMark Colorado Holdings LLC, BlackRock, Inc., RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, and TANG CAPITAL MANAGEMENT LLC.
This page lists
140
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.